Bluejay diagnostics, inc. reports first quarter 2022 financial results

Acton, mass., april 20, 2022 (globe newswire) -- bluejay diagnostics, inc. (nasdaq: bjdx) (“bluejay”, “the company”), a pre-revenue medical diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and monitoring of disease progression, today announced financial results for the quarter ended march 31, 2022.

BJDX Ratings Summary

BJDX Quant Ranking